Treatment Management and Factors Affecting Mortality in Retroperitoneal Hemorrhage Due to Cardiac Catheterization; Single Center Experience

Bleeding complications after cardiac catheterization have been reviewed previously, but there are very few studies on retroperitoneal hematoma and appropriate treatment of patients is not well defined. For this reason, the investigators aimed to analyze the clinical manifestations of retroperitoneal hematomas in a single center using a case-control study design, to analyze the treatment procedure determinants and consequently to provide an updated and usable treatment algorithm.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Treatment Procedure Mortality

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Retroperitoneal hematoma following cardiac catheterization

Exclusion criteria

Patients with retroperitoneal hematomas other than cardiac catheterization and patients with missing file records.

Treatment and study plan

Retroperitoneal hematoma due to cardiac catheterization

Procedure

Primary outcomes

Mortality

Time frame: 01/01/2010- 31/10/2016

Sponsors and collaborators

Lead sponsor

Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital

Other Gov

Registry information

Important dates

Study start: 2010
Primary completion: 2016
Study completion: 2016
First posted: Dec 30, 2016
Registry last updated: Jan 2, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed